Glanbia revenues up 26% to €2.7bn

Revenues at Glanbia increased by 26.2 per cent to €2.7 billion, according to its full year results.

The company said the successful integration of BSN, the company it acquired in January 2011 for $144 million, into its performance nutrition business enhanced strong organic growth across its nutritional businesses.

In a statement, group managing director John Moloney said: "These businesses continue to outpace market growth rates, driven by strong market positions and science based, customer focused innovation."

Mr Moloney said positive global dairy markets underpinned a solid performance by its Dairy Ireland division, despite challenges in the company's consumer products business.

EBITA at the company grew 22.8 per cent to €186.1 million in the year. Adjusted earnings per share grew 26.7 per cent to 48.22 cents. Dividend per share in respect of the full year increased 10 per cent to 8.27 cents.

The company says it expects the operating environment in 2012 to be more challenging than in recent years with current global economic uncertainty set to impact global dairy markets and fragile consumer confidence.

Their guidance for 2012 is for 5 - 7 per cent growth in adjusted earnings per share, on a constant currency basis.